Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Chronic Renal Failure

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 251 articles:
HTML format



Single Articles


    June 2020
  1. ELENBERG E, O'Mahony CA, Eldin KW
    Ruptured gallbladder in cystinosis renal transplant recipient.
    Kidney Int. 2020;97:1304.
    PubMed    


    May 2020
  2. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
    Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
    PubMed     Abstract available


  3. CHAUVIN KJ, Blake PG, Garg AX, Weir MA, et al
    Baclofen has a risk of encephalopathy in older adults receiving dialysis.
    Kidney Int. 2020 May 22. pii: S0085-2538(20)30552.
    PubMed     Abstract available


  4. GISELLA V, Silvia D, Giuseppe G, Maria DF, et al
    SARS-CoV2 in the peritoneal waste in a patient treated with peritoneal dialysis.
    Kidney Int. 2020 May 12. pii: S0085-2538(20)30531.
    PubMed    


  5. GOICOECHEA M, Sanchez Camara LA, Macias N, Munoz de Morales A, et al
    COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain.
    Kidney Int. 2020 May 10. pii: S0085-2538(20)30509.
    PubMed     Abstract available


  6. ALBERICI F, Delbarba E, Manenti C, Econimo L, et al
    A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.
    Kidney Int. 2020 May 8. pii: S0085-2538(20)30508.
    PubMed     Abstract available


  7. IKIZLER TA
    COVID-19 in Dialysis Patients: Adding a Few More Pieces to the Puzzle.
    Kidney Int. 2020 May 7. pii: S0085-2538(20)30510.
    PubMed     Abstract available


  8. JOUBRAN NI, Mansour FA, El-Haddad BN
    The Case | Turbid effluent dialysis fluid in a peritoneal dialysis patient.
    Kidney Int. 2020;97:1065-1066.
    PubMed    


  9. TING SW, Ger TY, Kuo G
    Cutaneous oxalosis presenting as subcutaneous nodules in a dialysis patient.
    Kidney Int. 2020;97:1063.
    PubMed    


  10. HARTE J, Chapagain A, Sarkany RPE, Chaudhri S, et al
    The Case | Bullous eruptions in end-stage renal failure.
    Kidney Int. 2020;97:1067-1068.
    PubMed    


    April 2020
  11. WYATT CM, Drueke TB
    Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
    Kidney Int. 2020;97:639-642.
    PubMed    


    March 2020
  12. FLYTHE JE, Chang TI, Gallagher MP, Lindley E, et al
    Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2020 Mar 8. pii: S0085-2538(20)30231.
    PubMed     Abstract available


  13. GOODLAD C, George S, Sandoval S, Mepham S, et al
    Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitis.
    Kidney Int. 2020 Mar 6. pii: S0085-2538(20)30225.
    PubMed     Abstract available


  14. MAALOULY C, Seront B, Morelle J, Jadoul M, et al
    The Case | Severe acute hypocalcemia in a patient on hemodialysis.
    Kidney Int. 2020;97:619-620.
    PubMed    


    February 2020
  15. WILLIAMS VR, Konvalinka A, Song X, Zhou X, et al
    Connectivity mapping of a chronic kidney disease progression signature identified lysine deacetylases as novel therapeutic targets.
    Kidney Int. 2020 Feb 19. pii: S0085-2538(20)30144.
    PubMed     Abstract available


  16. ZHU H, Liao J, Zhou X, Hong X, et al
    Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via alphavbeta6 integrin signaling.
    Kidney Int. 2020 Feb 17. pii: S0085-2538(20)30140.
    PubMed     Abstract available


  17. GRYP T, De Paepe K, Vanholder R, Kerckhof FM, et al
    Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Kidney Int. 2020 Feb 17. pii: S0085-2538(20)30142.
    PubMed     Abstract available


  18. FURUSHO T, Sohara E, Mandai S, Kikuchi H, et al
    Renal TNFalpha activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease.
    Kidney Int. 2020 Feb 8. pii: S0085-2538(19)31217.
    PubMed     Abstract available


  19. HUANG CF, Chiu YW, Yu ML
    Patient-centered outreach treatment toward micro-elimination of hepatitis C virus infection in hemodialysis patients.
    Kidney Int. 2020;97:421.
    PubMed    


    January 2020
  20. LALJI R, Francis A, Johnson DW, McCulloch M, et al
    Health disparities in access to kidney replacement therapy amongst children and adolescents with end-stage kidney disease in low- and lower-middle-income countries.
    Kidney Int. 2020 Jan 9. pii: S0085-2538(19)31252.
    PubMed    


  21. TERKER AS, de Caestecker M
    Modeling human disease: a mouse model of acute kidney injury to chronic kidney disease progression after cardiac arrest.
    Kidney Int. 2020;97:22-24.
    PubMed     Abstract available


  22. ALLAM SR, Madhrira MM, Memon IA, Tessier J, et al
    Invasive mucormycosis in a renal transplant recipient.
    Kidney Int. 2020;97:216.
    PubMed    


    December 2019
  23. EDMONSTON DL, Pun PH
    Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Dec 28. pii: S0085-2538(19)31317.
    PubMed    


  24. HANUDEL MR
    Ferric citrate: cardio- and renoprotective in chronic kidney disease?
    Kidney Int. 2019;96:1277-1279.
    PubMed     Abstract available


    November 2019
  25. LUO S, Grams ME
    Epidemiology research to foster improvement in chronic kidney disease care.
    Kidney Int. 2019 Nov 26. pii: S0085-2538(19)31151.
    PubMed     Abstract available


  26. HESSE B, Rovas A, Buscher K, Kusche-Vihrog K, et al
    Symmetric dimethylarginine in dysfunctional high-density lipoprotein mediates endothelial glycocalyx breakdown in chronic kidney disease.
    Kidney Int. 2019 Nov 13. pii: S0085-2538(19)31057.
    PubMed     Abstract available


  27. CHAN L, Beers K, Yau AA, Chauhan K, et al
    Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients.
    Kidney Int. 2019 Nov 9. pii: S0085-2538(19)31116.
    PubMed     Abstract available


  28. CHIANG HP, Chiu YW, Lee JJ, Hung CC, et al
    Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.
    Kidney Int. 2019 Nov 7. pii: S0085-2538(19)31114.
    PubMed     Abstract available


  29. LEON SJ, Tangri N
    The impact of epilepsy and its treatment in patients with end-stage renal disease.
    Kidney Int. 2019;96:1063-1065.
    PubMed     Abstract available


  30. SCHMIDT-LAUBER C, Buttner-Herold M, Schiffer M, Wiesener MS, et al
    Tuberculous granulomatous interstitial nephritis in a renal allograft.
    Kidney Int. 2019;96:1243.
    PubMed    


  31. LASTER M, Pereira RC, Salusky IB
    Unraveling the osteocyte in CKD-MBD post-renal transplantation.
    Kidney Int. 2019;96:1059-1061.
    PubMed     Abstract available


    October 2019
  32. BANE O, Hectors SJ, Gordic S, Kennedy P, et al
    Multiparametric magnetic resonance imaging shows promising results to assess renal transplant dysfunction with fibrosis.
    Kidney Int. 2019 Oct 30. pii: S0085-2538(19)31038.
    PubMed     Abstract available


  33. WYATT CM, Drueke TB
    Scratching the itch: a new therapeutic target for dialysis-associated pruritus?
    Kidney Int. 2019 Oct 25. pii: S0085-2538(19)31036.
    PubMed    


  34. KELLY DM, Rothwell PM
    Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines.
    Kidney Int. 2019 Oct 18. pii: S0085-2538(19)31020.
    PubMed     Abstract available


  35. MARWICK TH, Amann K, Bangalore S, Cavalcante JL, et al
    Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;96:836-849.
    PubMed     Abstract available


  36. SEKAR P, West BL, Henriksen KJ, Chang A, et al
    An incidental but pathognomonic finding in renal allograft biopsy.
    Kidney Int. 2019;96:1042.
    PubMed    


    September 2019
  37. PEDERSEN MS, Muller M, Rulicke T, Leitner N, et al
    Lymphangiogenesis in a mouse model of renal transplant rejection extends life span of the recipients.
    Kidney Int. 2019 Sep 3. pii: S0085-2538(19)30843.
    PubMed     Abstract available


  38. PONTICELLI C, Moroni G
    Is preeclampsia a risk for end-stage renal disease?
    Kidney Int. 2019;96:547-549.
    PubMed     Abstract available


  39. DAVIES SJ
    Reaching consensus on the important outcomes for peritoneal dialysis patients.
    Kidney Int. 2019;96:545-546.
    PubMed     Abstract available


  40. WILLIAMS ME
    Said the glucose sensor to the insulin pump: can glycemic control be improved in hospitalized ESRD patients with diabetes mellitus?
    Kidney Int. 2019;96:540-542.
    PubMed     Abstract available


    August 2019
  41. ORLANDI PF, Huang J, Fukagawa M, Hoy W, et al
    A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30837.
    PubMed     Abstract available


  42. FRANCIS C, Courbon G, Gerber C, Neuburg S, et al
    Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30842.
    PubMed     Abstract available


  43. KAMMER M, Heinzel A, Willency JA, Duffin KL, et al
    Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30841.
    PubMed     Abstract available


  44. PATERSON MR, Geurts AM, Kriegel AJ
    miR-146b-5p has a sex-specific role in renal and cardiac pathology in a rat model of chronic kidney disease.
    Kidney Int. 2019 Aug 16. pii: S0085-2538(19)30815.
    PubMed     Abstract available


  45. PORRINI E, Diaz JM, Moreso F, Lauzurrica R, et al
    Prediabetes is a risk factor for cardiovascular disease following renal transplantation.
    Kidney Int. 2019 Aug 14. pii: S0085-2538(19)30810.
    PubMed     Abstract available


  46. MENDLEY SR, Levin A, Correa-Rotter R, Joubert BR, et al
    Chronic kidney diseases in agricultural communities: report from a workshop.
    Kidney Int. 2019 Aug 2. pii: S0085-2538(19)30781.
    PubMed     Abstract available


  47. TAN J
    Forty-billion medical expenditure for dialysis patients in China.
    Kidney Int. 2019;96:523.
    PubMed    


  48. SEPE V, Rampino T, Libetta C
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019;96:522.
    PubMed    


  49. PHILIP NM, Naranje P, Bagchi S, Das CJ, et al
    Multiple abscesses in a renal transplant recipient.
    Kidney Int. 2019;96:526.
    PubMed    


  50. MATSUSHITA K, Saritas T, Eiwaz MB, McClellan N, et al
    The acute kidney injury to chronic kidney disease transition in a mouse model of acute cardiorenal syndrome emphasizes the role of inflammation.
    Kidney Int. 2019 Aug 1. pii: S0085-2538(19)30774.
    PubMed     Abstract available


    July 2019
  51. ALENCAR DE PINHO N, Levin A, Fukagawa M, Hoy WE, et al
    Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.
    Kidney Int. 2019 Jul 25. pii: S0085-2538(19)30512.
    PubMed     Abstract available


  52. FAUCON AL, Flamant M, Metzger M, Boffa JJ, et al
    Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
    Kidney Int. 2019 Jul 16. pii: S0085-2538(19)30704.
    PubMed     Abstract available


  53. KAUNDAL U, Ramachandran R, Arora A, Kenwar DB, et al
    B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients.
    Kidney Int. 2019;96:249-250.
    PubMed    


  54. SUGIYAMA T
    Chronic kidney disease and fracture risk: a mechanistic insight.
    Kidney Int. 2019;96:247.
    PubMed    


  55. WALTHER CP, Erickson KF
    The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins.
    Kidney Int. 2019;96:22-25.
    PubMed     Abstract available


    June 2019
  56. SHIRAZIAN S
    Depression in patients undergoing hemodialysis: time to treat.
    Kidney Int. 2019 Jun 3. pii: S0085-2538(19)30592.
    PubMed    



  57. Wyatt CM, Drueke TB. High-dose IV iron for anemia correction in chronic kidney disease. Kidney Int. 2019;95:727-730.
    Kidney Int. 2019;95:1518.
    PubMed    


  58. RAPHAEL KL
    The Dietary Approaches to Stop Hypertension (DASH) diet in chronic kidney disease: should we embrace it?
    Kidney Int. 2019;95:1296-1298.
    PubMed     Abstract available


    May 2019
  59. WADDY SP, Ward JB, Becerra AZ, Powers T, et al
    Epilepsy and antiseizure medications increase all-cause mortality in dialysis patients in the United States.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30514.
    PubMed     Abstract available


  60. ROSSING P, Block GA, Chin MP, Goldsberry A, et al
    Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30503.
    PubMed     Abstract available


  61. SISE ME, Chute DF, Oppong Y, Davis MI, et al
    Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30508.
    PubMed     Abstract available


  62. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Abstract available


  63. EGLI-SPICHTIG D, Imenez Silva PH, Glaudemans B, Gehring N, et al
    Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.
    Kidney Int. 2019 May 14. pii: S0085-2538(19)30465.
    PubMed     Abstract available


  64. COVELLA B, Vinturache AE, Cabiddu G, Attini R, et al
    A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia.
    Kidney Int. 2019 May 14. pii: S0085-2538(19)30502.
    PubMed     Abstract available


  65. FAZZINI F, Lamina C, Fendt L, Schultheiss UT, et al
    Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30483.
    PubMed     Abstract available


  66. HALLAN SI, Rifkin DE, Potok OA, Katz R, et al
    Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30484.
    PubMed     Abstract available


  67. CHEUNG AK, Chang TI, Cushman WC, Furth SL, et al
    Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;95:1027-1036.
    PubMed     Abstract available


  68. MAZZAFERRO S, Pasquali M
    Direct bone effects of calcimimetics in chronic kidney disease?
    Kidney Int. 2019;95:1012-1014.
    PubMed     Abstract available


  69. LEE LOY J, Koratala A, De Los Santos Y, Chamarthi G, et al
    Disseminated toxoplasmosis: a life-threatening complication of inadequate posttransplant prophylaxis.
    Kidney Int. 2019;95:1274.
    PubMed    


  70. YU ASL, Shen C, Landsittel DP, Grantham JJ, et al
    Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
    Kidney Int. 2019;95:1253-1261.
    PubMed     Abstract available


  71. DIAZ-TOCADOS JM, Rodriguez-Ortiz ME, Almaden Y, Pineda C, et al
    Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.
    Kidney Int. 2019;95:1064-1078.
    PubMed     Abstract available


    April 2019
  72. HOUSE AA, Wanner C, Sarnak MJ, Pina IL, et al
    Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276.
    PubMed     Abstract available


  73. CHAN CT, Blankestijn PJ, Dember LM, Gallieni M, et al
    Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 12. pii: S0085-2538(19)30138.
    PubMed     Abstract available


  74. JEONG JH, Biruete A, Tomayko EJ, Wu PT, et al
    Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients.
    Kidney Int. 2019 Apr 2. pii: S0085-2538(19)30389.
    PubMed     Abstract available


  75. JADOUL M, Bieber BA, Martin P, Akiba T, et al
    Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
    Kidney Int. 2019;95:939-947.
    PubMed     Abstract available


  76. ROSSIGNOL P, Frimat L, Zannad F
    The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
    Kidney Int. 2019;95:747-749.
    PubMed     Abstract available


  77. HE H, Li B, Gao X, Li H, et al
    A dialysis patient with isolated persistent left superior vena cava.
    Kidney Int. 2019;95:1000.
    PubMed    


  78. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.
    PubMed    



  79. Caplin B, Yang C-W, Anand S, et al., on behalf of International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology (i3C). The International Society of Nephrology's International Consortium o
    Kidney Int. 2019;95:997-998.
    PubMed    


  80. LANDAU SI, Guo X, Velazquez H, Torres R, et al
    Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
    Kidney Int. 2019;95:797-814.
    PubMed     Abstract available


  81. WYATT CM, Drueke TB
    High-dose IV iron for anemia correction in chronic kidney disease.
    Kidney Int. 2019;95:727-730.
    PubMed    


  82. SINGH G, Swamy A, Kumari K, Brijwal M, et al
    The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney Int. 2019;95:1001-1002.
    PubMed    


  83. GAILLARD F, Courbebaisse M, Kamar N, Rostaing L, et al
    Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.
    Kidney Int. 2019;95:896-904.
    PubMed     Abstract available


    March 2019
  84. MANERA KE, Tong A, Craig JC, Shen J, et al
    An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis.
    Kidney Int. 2019 Mar 29. pii: S0085-2538(19)30340.
    PubMed     Abstract available


  85. TAYLOR DM, Bradley JA, Bradley C, Draper H, et al
    Limited health literacy is associated with reduced access to kidney transplantation.
    Kidney Int. 2019 Mar 27. pii: S0085-2538(19)30049.
    PubMed     Abstract available


  86. MAYER GJ, Wanner C, Weir MR, Inzucchi SE, et al
    Analysis from the EMPA-REG OUTCOME((R)) trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.
    Kidney Int. 2019 Mar 21. pii: S0085-2538(19)30317.
    PubMed     Abstract available


  87. AZUKAITIS K, Ju W, Kirchner M, Nair V, et al
    Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30184.
    PubMed     Abstract available


  88. BALLY L, Gubler P, Thabit H, Hartnell S, et al
    Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30322.
    PubMed     Abstract available


  89. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Abstract available


  90. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Abstract available


  91. SCHLACKOW I, Kent S, Herrington W, Emberson J, et al
    Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
    Kidney Int. 2019 Mar 12. pii: S0085-2538(19)30171.
    PubMed     Abstract available


  92. ROSSING P, Persson F, Frimodt-Moller M
    Improvements in albuminuria and chronic kidney disease progression with the appetite suppressant lorcaserin.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30281.
    PubMed    


  93. ROWE C, Sitch AJ, Barratt J, Brettell EA, et al
    Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30274.
    PubMed     Abstract available


  94. BAI M, Chen H, Ding D, Song R, et al
    MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30114.
    PubMed     Abstract available


  95. LOUTRADIS C, Sarafidis PA, Ekart R, Papadopoulos C, et al
    The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30270.
    PubMed     Abstract available


  96. AGARWAL AK, Haddad NJ, Vachharajani TJ, Asif A, et al
    Innovations in vascular access for hemodialysis.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30103.
    PubMed     Abstract available


  97. MULAY SR
    Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30109.
    PubMed     Abstract available


  98. BANERJEE T, Crews DC, Tuot DS, Pavkov ME, et al
    Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30113.
    PubMed     Abstract available


  99. COMBALIA A, Munoz-Mahamud E, Cofan F
    Giant calcified mass in a hemodialysis patient.
    Kidney Int. 2019;95:719.
    PubMed    


  100. CHAMARTHI G, Koratala A
    Embedded peritoneal dialysis catheter.
    Kidney Int. 2019;95:718.
    PubMed    


  101. GORAYA N, Simoni J, Sager LN, Madias NE, et al
    Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Kidney Int. 2019 Mar 1. pii: S0085-2538(18)30945.
    PubMed     Abstract available


  102. SRIVASTAVA P, Solanki AK, Arif E, Wolf BJ, et al
    Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
    Kidney Int. 2019;95:708-716.
    PubMed     Abstract available


    February 2019
  103. SANCHIS P, Ho CY, Liu Y, Beltran LE, et al
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019 Feb 28. pii: S0085-2538(19)30035.
    PubMed     Abstract available


  104. XU H, Kuja-Halkola R, Chen X, Magnusson PKE, et al
    Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30047.
    PubMed     Abstract available


  105. WEWERS TM, Mayer AB, Pfleiderer A, Beul K, et al
    Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Kidney Int. 2019 Feb 22. pii: S0085-2538(18)30901.
    PubMed     Abstract available


  106. KIKUCHI K, Hamano T, Wada A, Nakai S, et al
    Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis.
    Kidney Int. 2019 Feb 16. pii: S0085-2538(18)30897.
    PubMed     Abstract available


  107. CONNAUGHTON DM, Kennedy C, Shril S, Mann N, et al
    Monogenic causes of chronic kidney disease in adults.
    Kidney Int. 2019 Feb 12. pii: S0085-2538(18)30839.
    PubMed     Abstract available


  108. TANASIYCHUK T, Kushnir DA, Antebi A, Frajewicki V, et al
    Paradoxically normal location of peritoneal dialysis catheter.
    Kidney Int. 2019;95:470.
    PubMed    


  109. EVENEPOEL P, Claes K, Cavalier E, Meijers B, et al
    A distinct bone phenotype in ADPKD patients with end-stage renal disease.
    Kidney Int. 2019;95:412-419.
    PubMed     Abstract available


  110. CANAUD B, Kooman J, Selby NM, Taal M, et al
    Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease.
    Kidney Int. 2019;95:296-309.
    PubMed     Abstract available


  111. HRUSKA KA, Mahjoub MR
    New pathogenic insights inform therapeutic target development for renal osteodystrophy.
    Kidney Int. 2019;95:261-263.
    PubMed     Abstract available


  112. NUVOLONE M, Merlini G
    Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Kidney Int. 2019;95:258-260.
    PubMed     Abstract available


  113. ZHUO M, Li J, Lecker SH
    Brugada phenocopy induced by hyperkalemia.
    Kidney Int. 2019;95:471.
    PubMed    


    January 2019
  114. HAMMER F, Malzahn U, Donhauser J, Betz C, et al
    A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.
    Kidney Int. 2019 Jan 29. pii: S0085-2538(18)30906.
    PubMed     Abstract available


  115. CONNOLLY R, Denton MD, Humphreys H, McLoughlin RM, et al
    Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?
    Kidney Int. 2019 Jan 26. pii: S0085-2538(18)30824.
    PubMed     Abstract available


  116. VIECELLI AK, Lok CE
    Hemodialysis vascular access in the elderly-getting it right.
    Kidney Int. 2019;95:38-49.
    PubMed     Abstract available


  117. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Abstract available


  118. CAPLIN B, Yang CW, Anand S, Levin A, et al
    The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dat
    Kidney Int. 2019;95:4-10.
    PubMed    


  119. CHEN Z, Zhang W, Chen X, Hsu CY, et al
    Trends in end-stage kidney disease in Shanghai, China.
    Kidney Int. 2019;95:232.
    PubMed    


  120. WANG J, Zhang L, Zhao MH
    The authors reply.
    Kidney Int. 2019;95:233.
    PubMed    


  121. TAKANO T, Bareke E, Takeda N, Aoudjit L, et al
    Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice.
    Kidney Int. 2019;95:57-61.
    PubMed     Abstract available


  122. SEE EJ, Jayasinghe K, Glassford N, Bailey M, et al
    Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure.
    Kidney Int. 2019;95:160-172.
    PubMed     Abstract available


    December 2018
  123. VERZOLA D, Barisione C, Picciotto D, Garibotto G, et al
    Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
    Kidney Int. 2018 Dec 28. pii: S0085-2538(18)30777.
    PubMed     Abstract available


  124. CHAUHAN K, Verghese DA, Rao V, Chan L, et al
    Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30772.
    PubMed     Abstract available


  125. ANGEL-KORMAN A, Stern L, Sarosiek S, Sloan JM, et al
    Long-term outcome of kidney transplantation in AL amyloidosis.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30774.
    PubMed     Abstract available


  126. WHITLOCK RH, Leslie WD, Shaw J, Rigatto C, et al
    The Fracture Risk Assessment Tool (FRAX(R)) predicts fracture risk in patients with chronic kidney disease.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30775.
    PubMed     Abstract available


  127. DEL RIO F, Andres A, Padilla M, Sanchez-Fructuoso AI, et al
    Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30717.
    PubMed     Abstract available


  128. ERPICUM P, Weekers L, Detry O, Bonvoisin C, et al
    Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Kidney Int. 2018 Dec 6. pii: S0085-2538(18)30712.
    PubMed     Abstract available


  129. LIAKOPOULOS V, Eleftheriadis T, Mertens PR
    Screening for renal cell carcinoma in dialysis patients.
    Kidney Int. 2018;94:1238.
    PubMed    


  130. KRONBICHLER A, Jayne DRW
    ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?
    Kidney Int. 2018;94:1045-1047.
    PubMed     Abstract available


  131. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.
    PubMed    


  132. YEN TH, Wang IK, Hsu CW
    Hemoperfusion for paraquat poisoning.
    Kidney Int. 2018;94:1239.
    PubMed    


  133. FISCHER RSB, Vangala C, Mandayam S, Chavarria D, et al
    Clinical markers to predict progression from acute to chronic kidney disease in Mesoamerican nephropathy.
    Kidney Int. 2018;94:1205-1216.
    PubMed     Abstract available


    November 2018
  134. CHARYTAN DM, Himmelfarb J, Ikizler TA, Raj DS, et al
    Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
    Kidney Int. 2018 Nov 22. pii: S0085-2538(18)30641.
    PubMed     Abstract available


  135. JOHNSON SC, Martinez F, Bitto A, Gonzalez B, et al
    mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Kidney Int. 2018 Nov 21. pii: S0085-2538(18)30645.
    PubMed     Abstract available


  136. KIKUCHI H, Sasaki E, Nomura N, Mori T, et al
    Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease.
    Kidney Int. 2018 Nov 13. pii: S0085-2538(18)30635.
    PubMed     Abstract available


  137. JIANG G, Luk AOY, Tam CHT, Xie F, et al
    Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30629.
    PubMed     Abstract available


  138. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Abstract available


  139. BOUCHARA A, Yi D, Pastural M, Granjon S, et al
    Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients.
    Kidney Int. 2018;94:983-992.
    PubMed     Abstract available


  140. WANG T, Zhan ZP, Yang L, Lu Y, et al
    Extreme manifestations of hyperparathyroidism in a hemodialysis patient.
    Kidney Int. 2018;94:1028.
    PubMed    


  141. SCHMITT R
    ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
    Kidney Int. 2018;94:858-860.
    PubMed     Abstract available


  142. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Abstract available


  143. KRAMER H, Soyibo A, Forrester T, Boyne M, et al
    The burden of chronic kidney disease and its major risk factors in Jamaica.
    Kidney Int. 2018;94:840-842.
    PubMed    



  144. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451.
    Kidney Int. 2018;94:1025-1026.
    PubMed    


    October 2018
  145. AGARWAL R, Tu W
    Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30608.
    PubMed     Abstract available


  146. BRIX SR, Noriega M, Tennstedt P, Vettorazzi E, et al
    Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30552.
    PubMed     Abstract available


  147. VYCHYTIL A, Herzog R, Probst P, Ribitsch W, et al
    A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
    Kidney Int. 2018 Oct 22. pii: S0085-2538(18)30637.
    PubMed     Abstract available


  148. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Abstract available


  149. KHAN SF, Rosner MH
    "Highlighting" an unusual case of discolored peritoneal dialysis effluent.
    Kidney Int. 2018;94:835.
    PubMed    


  150. PARFREY PS
    Evocalcet in the management of secondary hyperparathyroidism in dialysis patients.
    Kidney Int. 2018;94:661-662.
    PubMed     Abstract available


  151. ELEFTHERIADIS T, Pissas G, Liakopoulos V, Stefanidis I, et al
    Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia.
    Kidney Int. 2018;94:830-831.
    PubMed    


  152. SELISTRE L, Rabilloud M, De Souza V, Iwaz J, et al
    Regarding "Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease".
    Kidney Int. 2018;94:827-828.
    PubMed    


    September 2018
  153. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Abstract available


  154. SHAIKH M, Woodward M, John O, Bassi A, et al
    Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
    Kidney Int. 2018;94:440-445.
    PubMed    


    August 2018
  155. BLAKE PG
    Is the peritoneal dialysis biocompatibility hypothesis dead?
    Kidney Int. 2018;94:246-248.
    PubMed     Abstract available


  156. NIGWEKAR SU, Nazarian RM
    Cutaneous calcification in patients with kidney disease is not always calciphylaxis.
    Kidney Int. 2018;94:244-246.
    PubMed     Abstract available


    July 2018
  157. JHA V, Modi GK
    Getting to know the enemy better-the global burden of chronic kidney disease.
    Kidney Int. 2018 Jul 24. pii: S0085-2538(18)30362.
    PubMed     Abstract available


  158. YAMADA S, Leaf EM, Chia JJ, Cox TC, et al
    PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.
    Kidney Int. 2018 Jul 21. pii: S0085-2538(18)30389.
    PubMed     Abstract available


  159. FUKAGAWA M, Shimazaki R, Akizawa T
    Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30387.
    PubMed     Abstract available


  160. XIE Y, Bowe B, Mokdad AH, Xian H, et al
    Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.
    Kidney Int. 2018 Jul 5. pii: S0085-2538(18)30318.
    PubMed     Abstract available


  161. TANEMOTO M
    The analysis of hemoglobin A1c in dialysis patients should include the variables that reflect the erythrocyte turnover.
    Kidney Int. 2018;94:220-221.
    PubMed    


  162. RAYNER HC, Rosansky SJ
    The estimated glomerular filtration rate graph: another tool in the management of patients with advanced chronic kidney disease.
    Kidney Int. 2018;94:222.
    PubMed    


  163. HAWKINS CL
    Protein carbamylation: a key driver of vascular calcification during chronic kidney disease.
    Kidney Int. 2018;94:12-14.
    PubMed     Abstract available


    June 2018
  164. WANNER C, Herzog CA, Turakhia MP
    Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2018 Jun 20. pii: S0085-2538(18)30358.
    PubMed    


  165. KARABOYAS A, Xu H, Morgenstern H, Locatelli F, et al
    DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
    Kidney Int. 2018 Jun 13. pii: S0085-2538(18)30253.
    PubMed     Abstract available


  166. HU JR, Coresh J, Inker LA, Levey AS, et al
    Serum metabolites are associated with all-cause mortality in chronic kidney disease.
    Kidney Int. 2018 Jun 2. pii: S0085-2538(18)30247.
    PubMed     Abstract available


  167. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Abstract available


  168. WYATT CM, Wanner N
    Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults.
    Kidney Int. 2018;93:1260-1262.
    PubMed    


  169. QIU C, Hanson RL, Fufaa G, Kobes S, et al
    Cytosine methylation predicts renal function decline in American Indians.
    Kidney Int. 2018;93:1417-1431.
    PubMed     Abstract available


  170. NADKARNI GN, Chauhan K, Verghese DA, Parikh CR, et al
    Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Kidney Int. 2018;93:1409-1416.
    PubMed     Abstract available


    May 2018
  171. RABY AC, Gonzalez-Mateo GT, Williams A, Topley N, et al
    Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30254.
    PubMed     Abstract available


  172. DURLACHER-BETZER K, Hassan A, Levi R, Axelrod J, et al
    Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30240.
    PubMed     Abstract available


  173. TAM-THAM H, Quinn RR, Weaver RG, Zhang J, et al
    Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.
    Kidney Int. 2018 May 23. pii: S0085-2538(18)30246.
    PubMed     Abstract available


  174. ALEKSOVA J, Wong P, McLachlan R, Choy KW, et al
    Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30212.
    PubMed     Abstract available


  175. SCHAEFER B, Bartosova M, Macher-Goeppinger S, Sallay P, et al
    Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30213.
    PubMed     Abstract available


  176. ZHU L, Guo WY, Shi SF, Liu LJ, et al
    Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30214.
    PubMed     Abstract available


  177. GUMBER R, Cohen JB, Palmer MB, Kobrin SM, et al
    A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30211.
    PubMed     Abstract available


  178. ALRIC L, Ollivier-Hourmand I, Berard E, Hillaire S, et al
    Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30209.
    PubMed     Abstract available


  179. NG DK, Schwartz GJ, Schneider MF, Furth SL, et al
    Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30184.
    PubMed     Abstract available


  180. GOODKIN DA, Bieber B
    International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
    Kidney Int. 2018;93:1249.
    PubMed    


  181. FUSARO M, Cannata-Andia JB, Nickolas TL, Plebani M, et al
    Clinical relevance and future perspective of fractures in patients with chronic kidney disease.
    Kidney Int. 2018;93:1248.
    PubMed    


  182. STENGEL B
    Uncovering real mortality trends in ESRD patients.
    Kidney Int. 2018;93:1040-1043.
    PubMed     Abstract available


  183. HOMMOS MS, Zeng C, Liu Z, Troost JP, et al
    Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Kidney Int. 2018;93:1175-1182.
    PubMed     Abstract available


    April 2018
  184. NEVEN E, Vervaet B, Brand K, Gottwald-Hostalek U, et al
    Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30174.
    PubMed     Abstract available


  185. BARUTTA F, Bruno G, Mastrocola R, Bellini S, et al
    The role of cannabinoid signaling in acute and chronic kidney diseases.
    Kidney Int. 2018 Apr 26. pii: S0085-2538(18)30140.
    PubMed     Abstract available


  186. BRUCK K, Jager KJ, Zoccali C, Bello AK, et al
    Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30096.
    PubMed     Abstract available


  187. KALRA PA, Green D, Poulikakos D
    Arrhythmia in hemodialysis patients and its relation to sudden death.
    Kidney Int. 2018;93:781-783.
    PubMed     Abstract available


  188. LABRIOLA L, Jadoul M
    Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered.
    Kidney Int. 2018;93:1015-1016.
    PubMed    


  189. MATHEW RO, Bangalore S, Sidhu MS, Fleg JL, et al
    Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Kidney Int. 2018;93:787-788.
    PubMed    


  190. WATERS DD, Vogt L
    Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
    Kidney Int. 2018;93:784-786.
    PubMed     Abstract available


  191. PRASAD PV
    Update on renal blood oxygenation level-dependent MRI to assess intrarenal oxygenation in chronic kidney disease.
    Kidney Int. 2018;93:778-780.
    PubMed     Abstract available


  192. GRAUDAL N
    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    PubMed     Abstract available


  193. OOMATIA A, Dupont P, Bass P, Moochhala S, et al
    The Case | Shining a light on an unusual case of chronic kidney disease.
    Kidney Int. 2018;93:1023-1024.
    PubMed    


  194. VACHHARAJANI TJ, Agarwal AK, Asif A
    Vascular access of last resort.
    Kidney Int. 2018;93:797-802.
    PubMed     Abstract available


    March 2018
  195. GRAMS ME, Sang Y, Ballew SH, Carrero JJ, et al
    Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
    Kidney Int. 2018 Mar 24. pii: S0085-2538(18)30097.
    PubMed     Abstract available


  196. VERVLOET MG, van Ballegooijen AJ
    Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Kidney Int. 2018 Mar 23. pii: S0085-2538(18)30124.
    PubMed     Abstract available


  197. WANG J, Zhang L, Tang SC, Kashihara N, et al
    Disease burden and challenges of chronic kidney disease in North and East Asia.
    Kidney Int. 2018 Mar 21. pii: S0085-2538(18)30094.
    PubMed    


  198. PUN PH, Wyatt CM
    Utility of implantable cardioverter defibrillators in chronic kidney disease.
    Kidney Int. 2018 Mar 17. pii: S0085-2538(18)30196.
    PubMed    


  199. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Abstract available


  200. TOTH PP, Dwyer JP, Cannon CP, Colhoun HM, et al
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Kidney Int. 2018 Mar 8. pii: S0085-2538(18)30055.
    PubMed     Abstract available


  201. TONELLI M, Wiebe N, James MT, Klarenbach SW, et al
    A population-based cohort study defines prognoses in severe chronic kidney disease.
    Kidney Int. 2018 Mar 7. pii: S0085-2538(18)30057.
    PubMed     Abstract available


    February 2018
  202. RABBANI N, Thornalley PJ
    Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30051.
    PubMed     Abstract available


  203. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    PubMed     Abstract available


  204. SUMIDA K, Molnar MZ, Potukuchi PK, Hassan F, et al
    Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30893.
    PubMed     Abstract available


  205. NITSCH D
    Does dialysis modality affect the development of cognitive impairment?
    Kidney Int. 2018;93:306-308.
    PubMed     Abstract available


  206. DUSSO A, Colombo MI, Shanahan CM
    Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.
    Kidney Int. 2018;93:298-301.
    PubMed     Abstract available


  207. ORDUNEZ P, Hoy WE
    Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.
    Kidney Int. 2018;93:284-287.
    PubMed    


    January 2018
  208. STOREY BC, Staplin N, Harper CH, Haynes R, et al
    Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Kidney Int. 2018 Jan 30. pii: S0085-2538(17)30856.
    PubMed     Abstract available


  209. ROY-CHAUDHURY P, Tumlin JA, Koplan BA, Costea AI, et al
    Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30855.
    PubMed     Abstract available


  210. DOU L, Poitevin S, Sallee M, Addi T, et al
    Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30826.
    PubMed     Abstract available


  211. LIU BC, Tang TT, Lv LL, Lan HY, et al
    Renal tubule injury: a driving force toward chronic kidney disease.
    Kidney Int. 2018 Jan 17. pii: S0085-2538(17)30819.
    PubMed     Abstract available


  212. PRUIJM M, Milani B, Pivin E, Podhajska A, et al
    Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30800.
    PubMed     Abstract available


  213. LEE BJ, Go AS, Parikh R, Leong TK, et al
    Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30797.
    PubMed     Abstract available


  214. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Abstract available


  215. PERSSON F, Borg R
    YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
    Kidney Int. 2018;93:21-22.
    PubMed     Abstract available


  216. MARSHALL MR
    Intensive hemodialysis-keeping the faith.
    Kidney Int. 2018;93:10-12.
    PubMed     Abstract available


  217. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.
    PubMed    


  218. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.
    PubMed    


  219. FARRAH TE, Anand A, Miller-Hodges E, Mills NL, et al
    Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.
    Kidney Int. 2018;93:270.
    PubMed    


  220. CHEN Z, Li J, Yang Y, Li H, et al
    The renal artery is involved in Chinese Takayasu's arteritis patients.
    Kidney Int. 2018;93:245-251.
    PubMed     Abstract available


  221. TENNANKORE KK, Na Y, Wald R, Chan CT, et al
    Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival.
    Kidney Int. 2018;93:188-194.
    PubMed     Abstract available


    December 2017
  222. YU ASL, Shen C, Landsittel DP, Harris PC, et al
    Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Kidney Int. 2017 Dec 28. pii: S0085-2538(17)30785.
    PubMed     Abstract available


  223. ANDERS HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, et al
    The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30772.
    PubMed     Abstract available


  224. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Abstract available



  225. Moradi H, Said HM. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016;90:252-254.
    Kidney Int. 2017;92:1558.
    PubMed    



  226. Li L, Lai EY, Luo Z, et al. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Kidney Int. 2017;92:625-633.
    Kidney Int. 2017;92:1558.
    PubMed    



  227. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26-36.
    Kidney Int. 2017;92:1558.
    PubMed    


  228. ISAKA Y
    Adaptor protein is a new therapeutic target in chronic kidney disease.
    Kidney Int. 2017;92:1312-1314.
    PubMed     Abstract available


    November 2017
  229. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    PubMed     Abstract available


  230. WAGENSEIL JE
    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    PubMed     Abstract available


  231. LIN TY, Peng CH, Hung SC, Tarng DC, et al
    Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30663.
    PubMed     Abstract available


    October 2017
  232. SAWINSKI D, Forde KA, Locke JE, Cohen JB, et al
    Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
    Kidney Int. 2017 Oct 26. pii: S0085-2538(17)30612.
    PubMed     Abstract available


  233. NEUMANN D, Mau W, Wienke A, Girndt M, et al
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Kidney Int. 2017 Oct 14. pii: S0085-2538(17)30568.
    PubMed     Abstract available


  234. CHARYTAN DM, Skali H, Shah NR, Veeranna V, et al
    Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Kidney Int. 2017 Oct 13. pii: S0085-2538(17)30571.
    PubMed     Abstract available


  235. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    PubMed     Abstract available


  236. STREJA E
    Hospital readmission for the dialysis patient: who is (not) responsible?
    Kidney Int. 2017;92:788-790.
    PubMed     Abstract available


    September 2017
  237. PIMENTEL A, Urena-Torres P, Zillikens MC, Bover J, et al
    Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Kidney Int. 2017 Sep 27. pii: S0085-2538(17)30567.
    PubMed     Abstract available


  238. LORENZ G, Schmalenberg M, Kemmner S, Haller B, et al
    Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
    Kidney Int. 2017 Sep 20. pii: S0085-2538(17)30540.
    PubMed     Abstract available


  239. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    PubMed     Abstract available


  240. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    PubMed     Abstract available


    July 2017
  241. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Abstract available


    April 2017
  242. BIERZYNSKA A, McCarthy HJ, Soderquest K, Sen ES, et al
    Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Kidney Int. 2017;91:937-947.
    PubMed     Abstract available


    March 2017
  243. LOWENSTEIN J, Grantham JJ
    Residual renal function: a paradigm shift.
    Kidney Int. 2017;91:561-565.
    PubMed     Abstract available


  244. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Abstract available


    February 2017
  245. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    PubMed     Abstract available


  246. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    PubMed     Abstract available


  247. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    PubMed     Abstract available


    November 2016
  248. READY AR, Nath J, Milford DV, Adu D, et al
    Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Kidney Int. 2016;90:916-920.
    PubMed    


    August 2016
  249. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.
    PubMed    


    July 2016
  250. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Abstract available


    April 2016
  251. GILL J, Dong J, Rose C, Gill JS, et al
    The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Kidney Int. 2016 Apr 5. pii: S0085-2538(16)00324.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: